Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2773.0%
Neutral1027.0%
Bearish00.0%
FN2 Earnings Intelligence
Newmont Corporation complete analyst coverage
Newmont Corporation (NEM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$110.95Current
$57Low
$107.5Average
$175High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Freedom Broker | Hold | Buy | Downgrade | Oct 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 20, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 19, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 16, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 9, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Aug 12, 2026 |
| TD Cowen | Buy | Hold | Upgrade | Jul 14, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 24, 2026 |
| CIBC | Outperform | Outperform | Maintain | Apr 21, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Sep 23, 2025 |
| Macquarie | Neutral | Outperform | Downgrade | Sep 2, 2025 |
| JP Morgan | Overweight | Neutral | Upgrade | Nov 19, 2024 |
| Argus Research | Buy | Hold | Upgrade | Aug 29, 2024 |
| TD Securities | Hold | Hold | Maintain | Apr 29, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 21, 2023 |
| Canaccord Genuity | Buy | Hold | Upgrade | Mar 14, 2023 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Feb 13, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Apr 19, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 17, 2020 |
| B. Riley Securities | Buy | Buy | Maintain | May 19, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | May 19, 2020 |
| B. Riley | Buy | Neutral | Upgrade | Jan 13, 2020 |
| Citi | Buy | Neutral | Upgrade | May 23, 2019 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jun 12, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bank of America | Buy | Buy | Maintain | Feb 26, 2018 |
| Standpoint Research | Buy | Hold | Upgrade | Dec 29, 2016 |
| Mackie Research | Buy | Hold | Upgrade | Oct 31, 2016 |
| Clarksons Platou | Neutral | Buy | Downgrade | Apr 18, 2016 |
| Clarkson Capital Markets | Neutral | Buy | Downgrade | Apr 18, 2016 |
| FBR Capital | Market Perform | Market Perform | Maintain | Jan 28, 2016 |
| HSBC | Hold | Buy | Downgrade | Oct 26, 2015 |
| BB&T Capital | Hold | Buy | Downgrade | Nov 3, 2014 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Sep 9, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $110.95. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $123 | $118.6 | +10.9% | Oct 19, 2026 |
| CIBC | Analyst unavailable | $154 | $119.56 | +38.8% | Oct 16, 2026 |
| Bernstein | Analyst unavailable | $144 | $127.09 | +29.8% | Sep 9, 2026 |
| Raymond James | Brian MacArthur | $140 | $130.96 | +26.2% | Aug 24, 2026 |
| CIBC | Analyst unavailable | $170 | $117.85 | +53.2% | Aug 14, 2026 |
| Scotiabank | Analyst unavailable | $149 | $119.62 | +34.3% | Aug 12, 2026 |
| Argus Research | Alexandra Yates | $110 | $93.87 | -0.9% | Aug 3, 2026 |
| CIBC | Anita Soni | $168 | $91.64 | +51.4% | Jul 28, 2026 |
| Barclays | Richard Garchitorena | $124 | $93.47 | +11.8% | Jul 28, 2026 |
| Barclays | Analyst unavailable | $125 | $95.04 | +12.7% | Jul 15, 2026 |
| Scotiabank | Analyst unavailable | $147 | $94.88 | +32.5% | Jul 14, 2026 |
| RBC Capital | Josh Wolfson | $135 | $94.52 | +21.7% | Jul 9, 2026 |
| Jefferies | Analyst unavailable | $146 | $97.04 | +31.6% | Jul 6, 2026 |
| UBS | Analyst unavailable | $120 | $92.34 | +8.2% | Jun 30, 2026 |
| CIBC | Anita Soni | $175 | $107.23 | +57.7% | Jun 1, 2026 |
| Barclays | Analyst unavailable | $133 | $108.33 | +19.9% | May 21, 2026 |
| TD Securities | Steven Green | $129 | $120.7 | +16.3% | Apr 27, 2026 |
| BMO Capital | Matthew Murphy | $145 | $117.87 | +30.7% | Apr 24, 2026 |
| CIBC | Anita Soni | $176 | $110.51 | +58.6% | Apr 21, 2026 |
| National Bank | Shane Nagle | $130 | $113.41 | +17.2% | Apr 16, 2026 |
| UBS | Analyst unavailable | $140 | $102.1 | +26.2% | Mar 27, 2026 |
| BMO Capital | Matthew Murphy | $140 | $121.02 | +26.2% | Feb 20, 2026 |
| Stifel Nicolaus | Analyst unavailable | $175 | $120.39 | +57.7% | Feb 10, 2026 |
| CIBC | Analyst unavailable | $177 | $114.36 | +59.5% | Feb 4, 2026 |
| UBS | Analyst unavailable | $160 | $117.25 | +44.2% | Jan 30, 2026 |
| Scotiabank | Analyst unavailable | $152 | $128.69 | +37.0% | Jan 26, 2026 |
| Raymond James | Analyst unavailable | $111 | $100.47 | +0.0% | Dec 29, 2025 |
| Jefferies | Fahad Tariq | $120 | $89.76 | +8.2% | Dec 7, 2025 |
| BNP Paribas | Analyst unavailable | $97 | $90.72 | -12.6% | Dec 5, 2025 |
| UBS | Daniel Major | $125 | $91.82 | +12.7% | Dec 1, 2025 |
| Raymond James | Brian MacArthur | $99 | $83.31 | -10.8% | Oct 24, 2025 |
| Scotiabank | Analyst unavailable | $114 | $87.01 | +2.7% | Oct 23, 2025 |
| UBS | Analyst unavailable | $105.5 | $93.58 | -4.9% | Oct 16, 2025 |
| Goldman Sachs | Analyst unavailable | $104.3 | $85.14 | -6.0% | Oct 12, 2025 |
| Raymond James | Brian MacArthur | $96 | $85.21 | -13.5% | Oct 10, 2025 |
| CIBC | Analyst unavailable | $112 | $85.21 | +0.9% | Oct 10, 2025 |
| RBC Capital | Josh Wolfson | $95 | $75.92 | -14.4% | Sep 9, 2025 |
| Macquarie | Andrew Bowler | $72 | $74.4 | -35.1% | Sep 1, 2025 |
| CIBC | Anita Soni | $74 | $57.35 | -33.3% | Jul 15, 2025 |
| Argus Research | John Eade | $63 | $53.68 | -43.2% | Apr 25, 2025 |
| Raymond James | Analyst unavailable | $66 | $53.94 | -40.5% | Apr 25, 2025 |
| UBS | Daniel Major | $54 | $47.8 | -51.3% | Oct 30, 2024 |
| RBC Capital | Josh Wolfson | $53 | $57.74 | -52.2% | Oct 24, 2024 |
| Jefferies | Matthew Murphy | $63 | $53.04 | -43.2% | Oct 4, 2024 |
| Jefferies | Matthew Murphy | $54 | $51.3 | -51.3% | Sep 10, 2024 |
| Argus Research | John Eade | $58 | $51.83 | -47.7% | Aug 29, 2024 |
| Scotiabank | Tanya Jakusconek | $59 | $51.19 | -46.8% | Aug 19, 2024 |
| BMO Capital | Jackie Przybylowski | $57 | $47.7 | -48.6% | Jul 25, 2024 |
| CIBC | Anita Soni | $61 | $45.36 | -45.0% | Jul 10, 2024 |
| UBS | Daniel Major | $50 | $40.97 | -54.9% | Jun 17, 2024 |
| Scotiabank | Tanya Jakusconek | $48 | $41.28 | -56.7% | May 23, 2024 |
| Goldman Sachs | Emily Chieng | $67 | $41.02 | -39.6% | Dec 15, 2023 |
| RBC Capital | Josh Wolfson | $60 | $45.61 | -45.9% | Jul 27, 2022 |
| Canaccord Genuity | Carey MacRury | $60 | $46.14 | -45.9% | Jul 26, 2022 |
| Canaccord Genuity | Analyst unavailable | $80 | $73.43 | -27.9% | Apr 26, 2022 |
| Fundamental Research | Siddharth Rajeev | $63.1 | $55.25 | -43.1% | Nov 8, 2021 |
| CIBC | Anita Soni | $69 | $53.09 | -37.8% | Oct 29, 2021 |
| TD Securities | Greg Barnes | $70 | $58.82 | -36.9% | Jul 26, 2021 |
| Desjardins | John Sclodnick | $85.94 | $71.39 | -22.5% | May 20, 2021 |
| Argus Research | David Coleman | $73 | $62.68 | -34.2% | May 5, 2021 |
| BMO Capital | Andrew Kaip | $85 | $60.33 | -23.4% | Apr 30, 2021 |
Track every rating change on NEM the moment it posts. Free to start.
Start freeGet the NEM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.